At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 31 enrolled
Drug / intervention
VVD-101 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-Center, Double-Blind, Placebo Controlled Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
In Brief
A Phase 2 clinical trial evaluating VVD-101 and Placebo for Delayed Alcohol Induced Headache. Completed, enrolled 31 participants across 2 sites.
Detailed Summary
This study proposes to compare the efficacy of sumatriptan and aspirin to placebo as an acute abortive treatment for delayed alcohol induced headache in adult subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDelayed Alcohol Induced Headache
CountriesUnited States
CollaboratorsVivid Pharma Inc.
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2014
Enrollment StartJul 2014
Primary CompletionJan 2016
TodayJul 2026
First PostedJun 27, 2014
Enrollment StartJul 1, 2014
Primary CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 12.0 years ago
Interventions
VVD-101drug
All subjects will treat 6 headaches with either VVD-101 or placebo in a randomized order.
Placebodrug
All subjects will treat 6 headaches with either VVD-101 or placebo in a randomized order.